| Identification | Back Directory | [Name]
3,7,12-trihydroxy-7-methylcholanoic acid | [CAS]
102362-49-2 | [Synonyms]
3,7,12-trihydroxy-7-methylcholanoic acid
3α,7α,12α-trihydroxy-7β-methyl-5β-cholanic acid
Cholan-24-oic acid, 3,7,12-trihydroxy-7-methyl-, (3α,5β,7α,12α)-
(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-7,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | [Molecular Formula]
C25H42O5 | [MDL Number]
MFCD34167251 | [MOL File]
102362-49-2.mol | [Molecular Weight]
422.6 |
| Chemical Properties | Back Directory | [Melting point ]
224 °C(Solvent: Acetone) | [Boiling point ]
583.6±50.0 °C(Predicted) | [density ]
1.163±0.06 g/cm3(Predicted) | [pka]
4.76±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
Antitumor agent-193 (Compound 13) has antitumor effect, but has no activity against normal cell line MRC-5[1]. | [References]
[1] Bjedov S, et al. Synthesis and antitumor activity of alkylated bile acids and oxazolines. Tetrahedron, 2017, 73(49): 6932-6941. |
|
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
|